Nanosized Trojan horses created from a patient’s own immune cells have successfully treated inflammation by overcoming the body’s complex defense mechanisms, perhaps leading to broader applications for treating diseases characterized by inflammation, such as cancer and cardiovascular diseases.
An international team, led by researchers at Houston Methodist Research Institute, described the creation of nanoparticles called leukosomes and evaluated their ability to treat localized inflammation in the May 23 issue of Nature Materials (early online).
Recent approaches to treating inflammatory diseases have been unsuccessful because an already overactive immune system treats simple nanoparticles as foreign invaders and clears them from the body, preventing them from reaching their target.
“A better approach for building effective drug delivery platforms is to find inspiration for their design in the composition of the immune cells of our body,” said Ennio Tasciotti, Ph.D., director of the Center for Biomimetic Medicine at Houston Methodist Research Institute and the paper’s senior author. “Immune cells such as leukocytes freely circulate in blood vessels, recognize inflammation, and accumulate in inflamed tissues. They do so by using special receptors and ligands on their surface. We purified leukocytes from a patient, then integrated their special ligands and receptors into the leukosome surface. Using the body’s own materials, we built a drug delivery system camouflaged as our own body’s defense system—thus the Trojan horse.”
In its normal form, acute inflammation is a necessary and beneficial part of the body’s defense against infection. However, under certain conditions, inflammation can turn from a friend to a vicious foe, damaging or destroying healthy cells. This is the case for autoimmune disorders such as rheumatoid arthritis, lupus and inflammatory bowel disease, or in illnesses such as Alzheimer’s, cancer, cardiovascular disease and Type 2 diabetes.
Leukosomes are able to target inflamed tissues because they retain the same surface properties of the immune cell membranes from which they are made. To evaluate leukosomes’ effectiveness as drug carriers, Tasciotti and his colleagues created vesicles from mouse leukocytes and filled them with dexamethasone (DXM), an anti-inflammatory agent.
“We used ‘personalized’ DXM-loaded leukosomes to treat inflammation in mice,” Tasciotti said. “After administering the leukosomes, we observed their attachment to the surface of blood vessels surrounding the inflamed tissue, and they selectively delivered DXM to the affected cells.”
The treated mice showed definite signs of improvement, including resolution of the inflammation, a significant reduction in tissue thickness, and a reversal of the immune response that is commonly seen in inflammation.
The success of the team’s initial leukosome trial is encouraging, Tasciotti said, and suggests that membranes purified from any other cell types could also be used as biomimetic nanocarriers to treat other diseases.
“By combining cell biology with nanotechnology, we can create valuable medical tools that work within, and not around, the laws of nature,” he said.
Learn more: Nanoscale trojan horses treat inflammation
The Latest on: Treating inflammation
[google_news title=”” keyword=”treating inflammation” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Treating inflammation
- Scientists at Feinstein Institutes find ultrasound neuromodulation promises to treat pulmonary hypertensionon May 9, 2024 at 3:30 am
Scientists at Feinstein Institutes find ultrasound neuromodulation promises to treat pulmonary hypertension: Manhasset, New York Thursday, May 9, 2024, 16:00 Hrs [IST] Bioelectron ...
- What is osteoarthritis? Here are 3 things to know about treatmenton May 9, 2024 at 2:03 am
Osteoarthritis is inflammation of the joints that comes from years of wear and tear. Here are three things to know that may help you feel better.
- The Role of Iron in Allergic Asthma Could Be Targeted in Potential New Treatmentson May 9, 2024 at 1:21 am
Iron drives inflammation in the lungs during an allergic asthma attack, presenting a target for new treatments.
- Microneedle Magic: New Alopecia Treatment Can Reverse Hair Losson May 8, 2024 at 11:13 pm
A new microneedle patch effectively treats alopecia areata by rebalancing the immune response locally, promoting hair regrowth and reducing inflammation without systemic side effects. Researchers at ...
- inflammatory protein research offers treatment strategies for a rare, potentially fatal lung diseaseon May 8, 2024 at 9:13 am
Most of the time, our immune systems do a great job defending against infection and keeping our bodies running smoothly. Sometimes, though, our immune system actually makes things worse. Case in point ...
- Investigational Drugs for Chronic Inflammatory Demyelinating Polyneuropathyon May 7, 2024 at 9:00 pm
Investigational therapies may soon change the treatment landscape for chronic inflammatory demyelinating polyneuropathy (CIDP)."Despite the fact that we have some good standard-of-care therapies -- ...
- A potential treatment for inflammatory bowel disease: Engineered yeast can transport medicines and lower inflammationon May 7, 2024 at 9:48 am
Inflammatory bowel disease (IBD) is a complex condition that requires individualized care to meet the needs of the patient's current disease state. With available medications sometimes causing serious ...
- Gut bacteria metabolite shows promise in fighting inflammatory bowel diseaseon May 7, 2024 at 7:34 am
Gut microbiota or the population of microbial inhabitants in the intestine, plays a key role in digestion and maintenance of overall health. Any disturbance in the gut microbiota can, therefore, have ...
- Evidence Builds to Support Colchicine in Treating Atherosclerotic Cardiovascular Diseaseon May 6, 2024 at 8:32 am
Colchicine, a legacy drug that received a new indication in 2023 for cardiovascular disease, can treat arterial inflammation after a heart attack, a principal investigator of clinical trials said.
- A wild orangutan used a medicinal plant to treat a wound, scientists sayon May 3, 2024 at 10:38 am
Researchers say an orangutan appeared to treat a wound with medicine from a tropical plant. It's the latest example of how some animals attempt to soothe their own ills with remedies found in the wild ...
via Bing News